Nanovibronix (NAOV)
(Delayed Data from NSDQ)
$0.69 USD
-0.02 (-2.94%)
Updated Sep 20, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nanovibronix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2 | 1 | 2 | 1 | 1 |
Cost Of Goods | 1 | 1 | 1 | 0 | 0 |
Gross Profit | 2 | 0 | 1 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 5 | 5 | 6 | 5 | 5 |
Income After Depreciation & Amortization | -3 | -5 | -6 | -5 | -5 |
Non-Operating Income | 0 | 0 | -9 | 1 | -1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -4 | -5 | -14 | -4 | -6 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -5 | -14 | -4 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4 | -5 | -14 | -4 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -3 | -5 | -6 | -5 | -5 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -3 | -5 | -6 | -5 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.75 | 1.42 | NA | NA | 0.35 |
Diluted EPS Before Non-Recurring Items | -2.12 | -3.84 | NA | NA | -16.60 |
Diluted Net EPS (GAAP) | -2.12 | -3.84 | -11.40 | -8.40 | -16.60 |
Fiscal Year end for Nanovibronix, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.82 | 0.92 | 1.18 | 0.46 | 0.29 |
Cost Of Goods | 0.39 | 0.26 | 0.44 | 0.11 | 0.08 |
Gross Profit | 0.43 | 0.66 | 0.74 | 0.35 | 0.22 |
SG&A, R&D, and Dept/Amort Expenses | 1.11 | 1.23 | 1.44 | 1.02 | 1.23 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.68 | -0.57 | -0.70 | -0.67 | -1.01 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.01 | 0.01 | 0.10 | 0.05 | 0.05 |
Pretax Income | -0.68 | -0.58 | -0.80 | -0.72 | -1.06 |
Income Taxes | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.69 | -0.59 | -0.81 | -0.73 | -1.07 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.69 | -0.59 | -0.81 | -0.73 | -1.07 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 2.78 | 2.51 | 2.06 | 1.72 | 1.66 |
Diluted EPS Before Non-Recurring Items | -0.25 | -0.23 | -0.39 | -0.42 | -0.65 |
Diluted Net EPS (GAAP) | -0.25 | -0.23 | -0.38 | -0.42 | -0.65 |